WANG Yi
Chief Executive Officer
WAN Ji
Chief Information Officer
ZHAO Zhao
Chief Technology Officer
PhD, Carnegie Mellon University, USA
Post-doctor,Harvard Medical School, USA
Ex-Research Fellow, Dana-Farber Cancer Institute, Harvard Medical School
Expertise in immune vaccine delivery technology
Published more than 10 research papers in internationally prestigious journals such as Science
One U.S. patent of invention
Ex-Instructor and Associate Research Fellow of Harvard Medical School, USA
Expertise in tumor immunotherapy, immune and metabolism, and novel vaccine development and application
More than 30 papers published in Nature (2016, 2017, 2019,2022), Science, Cell, Immunity, and npj Vaccines, cited by over 3000 times
Winner of the Harvard Chinese Life Sciences
Distinguished Research Award
Innovation Discovery Award, Partners Healthcare, USA
Sanofi Award for Exceptional Young Scientists, and other prizes
PhD, The University of Iowa, USA
Post-doctor, Cornell University, USA
Expertise in artificial intelligence and bioinformatics development
Author of the immune epitope antigen prediction software SVRMHC and MATHLA
25 papers published in journals such as Nature, Nature Methods, and Nature Machine Intelligence, cited by more than 2200 times
PhD, Arizona State University, USA
Post-doctor,Wyss Institute for Biologically Inspired Engineering at Harvard University
Expertise in Molecular biochemistryat Dana-Farber Cancer Institute at Harvard Medical School
More than 10 years of experiences in biomolecular engineering and treatment, as well as vaccine development
15 papers published in journals such as Science and Nature Comm
PAN Youdong
Chief Scientific Officer